Tunable light and drug induced depletion of target proteins

Wen Deng1, Jack A Bates1, Hai Wei1

  • 1Department of Biology II, Ludwig-Maximilians-Universität München, Munich, Germany.

Nature Communications
|January 18, 2020
PubMed

Insights

Researchers created new tools for controlling protein levels using light or drugs. These tools enable precise protein depletion for studying essential biological processes like DNA repair and apoptosis in model organisms.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Developmental Biology

Background:

  • Cellular protein dynamics are crucial for biological processes, development, and disease.
  • Understanding protein function requires precise control over their abundance and localization.

Purpose of the Study:

  • To develop novel, tunable, and reversible tools for targeted protein depletion.
  • To investigate the roles of essential proteins in cellular processes and organism development.

Main Methods:

  • Utilized recombinant E3 ubiquitin ligases controlled by light or drug-induced heterodimerization.
  • Employed nanobodies or DARPins for targeted depletion of endogenous proteins in cells and organisms.
  • Applied the system to study PCNA in DNA repair and CED-3 in apoptosis in *C. elegans*.

Main Results:

  • Demonstrated rapid, tunable, and reversible depletion of endogenous proteins.
  • Successfully used the tools for functional studies of essential proteins like PCNA and CED-3.
  • Showcased the potential for combined spatial and temporal protein depletion.

Conclusions:

  • Developed versatile tools for precise control of protein levels.
  • These tools facilitate the study of essential proteins and complex biological networks.
  • Enabled distinction between immediate and long-term cellular responses.

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.9K
Nonlinear Pharmacokinetics: Causes of Nonlinearity01:22

Nonlinear Pharmacokinetics: Causes of Nonlinearity

Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
626
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
161
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
284
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.5K